頁籤選單縮合
題名 | 妥瑞症的藥物治療=Pharmacological Treatment of Tourette Syndrome |
---|---|
作者 | 彭虹迪; 吳坦螢; 洪嘉琪; 魏沛瀅; 廖玲巧; Peng, Hung-ti; Wu, Tan-ying; Hung, Chia-chi; Wei, Pei-ying; Liao, Lin-chu; |
期刊 | 藥學雜誌 |
出版日期 | 20180300 |
卷期 | 34:1=134 2018.03[民107.03] |
頁次 | 頁33-38 |
分類號 | 415.989 |
語文 | chi |
關鍵詞 | 妥瑞症; Tourette syndrome; Tic; |
中文摘要 | 妥瑞症 (Tourette Syndrome, TS) 是一種遺傳性的神經疾病,患者因為身體不自覺抽 動 (Tic) 及聲帶不自覺發出聲響,加上社會因不了解 TS 而產生誤解,使患者生理及心 理飽受煎熬,甚至不少患者因此自殺。TS 目前並無法根治,主要為症狀治療,可由習 慣反向訓練 (Habit Reversal training, HRT) 及藥物治療兩方面著手,本篇主要是探討目 前 TS 藥物治療指引及同時有合併症的治療方法。 |
英文摘要 | Tourette Syndrome (TS) is an inherited neurological disorder characterized by repeated involuntary movements and uncontrollable vocal sounds called tics. Although there is no cure for TS, there are treatments to help manage the tics caused by TS. Newer antipsychotics and norepinephrine agents have been superior to older antipsychotics. The current guidelines do not contain dosage recommendations of each agent. Dosage should start low and gradually increase with close monitoring of response and adverse reactions. Compare risks and benefits of common medications used for TS is the primary goal of medication selection. |
本系統之摘要資訊系依該期刊論文摘要之資訊為主。